Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Baseline HIV genotype drug resistance testing: is it time for more or less?

AIDS (London, England) - 1 Aug 2022

Wood Brian R, Stekler Joanne D

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Viral
Share to Genotype
Share to HIV

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to Microbial Sensitivity Tests

Source

Identifiers

PMID: 35876702
DOI: 10.1097/QAD.0000000000003228

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Baseline HIV genotype drug resistance testing: is it time for more or less?PMID 35876702Read ↗

HIV drug resistance testing: an update for the clinician.Semantic proximity Read ↗

Is resistance testing of benefit in treatment-naive HIV-infected patients?Semantic proximity Read ↗

HIV drug resistance and you. Using resistance testing in clinical practice. U.S. guidelines, cost, limitations--and usefulness.Semantic proximity Read ↗

HIV drug resistance testing.Semantic proximity Read ↗

Resistance testing comes of age.Semantic proximity Read ↗

HIV drug resistance and you. The limitations of drug resistance testing. Many factors influence the results.Semantic proximity Read ↗

Genotype testing for all HIV patients, study suggests. Resistance is 18 percent overall.Semantic proximity Read ↗

HIV drug resistance testing: data be damned.Semantic proximity Read ↗

Guideline watch. Antiretroviral drug resistance testing--updated guidelines from the IAS-USA.Semantic proximity Read ↗

Time to genotype for selection of antiretroviral regimens in previously treated patients?Semantic proximity Read ↗

Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control studySemantic proximity Read ↗

The benefits of HIV resistance testing in optimizing drug discovery.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.